Evidence map›Paper›PMID 24326598›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2014

Antiretroviral therapy restores age-dependent loss of resting memory B cells in young HIV-infected Zambian children.

Kaitlin Rainwater-Lovett, Hope C Nkamba, Mwnagelwa Mubiana-Mbewe, Carolyn B Moore, Joseph B Margolick, William J Moss

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Kaitlin Rainwater-Lovett*Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; †Virology Laboratory, University Teaching Hospital, Lusaka, Zambia; ‡Center for Infectious Disease Research-Zambia, Lusaka, Zambia; §Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Alabama, AL; and ‖W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Dr Rainwater-Lovett is now with the Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD; Carolyn B. Moore is now with Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, NC).
Hope C Nkamba
Mwnagelwa Mubiana-Mbewe
Carolyn B Moore
Joseph B Margolick
William J Moss
Johns Hopkins University · USCentre for Infectious Disease Research in Zambia · ZMUniversity of Alabama at Birmingham · USUniversity Teaching Hospital · ZM

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
Immune Reconstitution of HIV-1 Infected Zambian Children Initiating AntiretroviraR01AI070018 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MOSS, WILLIAM J · 2007 to 2011
$1.8M
NCATS NIH HHS UL1 TR001079NIAID NIH HHS R01 AI070018
6 · The paper itself

Abstract

backgroundAntiretroviral therapy (ART) is associated with incomplete restoration of resting memory B (RMB) cell percentages in adults infected with HIV, but the effects on RMB cells in children are less well defined, in part because changes in RMB cell percentages are confounded by the development and maturation of the RMB cell pool. The objective of this study was to assess the effect of age at ART initiation on RMB cell percentages over time in HIV-infected Zambian children.

methodsRMB cell percentages (CD19CD21CD27) were measured by flow cytometry in 146 HIV-infected Zambian children (9-120 months old) at baseline and at 3-month intervals after ART initiation and in 34 control children at a single study visit.

resultsRMB cell percentages among untreated HIV-infected children younger than 24 months did not differ from those of control children (P = 0.97). Among HIV-infected children older than 24 months of age, however, each 12-month increase in age at ART initiation was associated with a 1.8% decrease in RMB cell percentage. In contrast, RMB cell percentages in control children up to 48 months increased 4.4% with each 12-month increase in age. After 12 months of ART, children aged 24-60 months had a significant increase in RMB cell percentages that no longer differed from those of control children.

conclusionsInitiation of ART in 2- to 5-year-old HIV-infected children resulted in reconstitution of RMB cell percentages to levels similar to control children and may help restore normal development and maintenance of B-cell immunity.

Indexed as

Immunologic MemoryAge FactorsAntigens, CD19Anti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveB-LymphocytesChildChild, PreschoolCohort StudiesFemaleFlow CytometryHIV InfectionsHumansInfantLymphocyte SubsetsMaleAntigens, CD19Anti-Retroviral AgentsReceptors, Complement 3dTumor Necrosis Factor Receptor Superfamily, Member 7

Identifiers

PMID24326598
PMCPMC3999252
OpenAlexW2056573996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.